Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
appellate, bore, effectuate, electroporation, fall, Favorito, immunology, judgement, kinase, Mirai, NMPA, OTCQX, paused, Pfizer, preemptive, preserve, regenerative, restarted, space, stay, stockover, tyrosine, unrest, Zevra
Removed:
AACR, accounted, al, amortization, Anderson, articling, ASX, cancelled, capitalization, cardiovascular, ceased, Celldex, center, centered, cerebral, CFDA, chemoradiation, CI, closure, communicable, complexity, comprising, conclude, contracting, correction, correlate, CSF, cutaneously, CXSP, daily, de, delivered, description, Diploma, divided, driven, economy, emerge, encouraging, Epizyme, explore, fluid, forcing, forfeited, fourteen, Fraser, geography, Guangzhou, heightened, Identifier, ImmunoCellular, ImmunoGen, inactivated, Incyte, infected, Infinity, Inflazyme, initiated, integrated, interval, investigate, irradiation, John, joining, kidney, leader, lieu, liver, LJPC, MD, merge, Merrimack, mOS, MTD, multicenter, Murphy, negotiated, NeuroOncology, novo, Onconova, OS, outbreak, pandemic, PFS, Pharmacokinetic, plasma, platinum, preventative, prolonged, promissory, proposal, protective, Pt, Pulmonary, Puma, RANO, ratio, recession, recurred, Reorganization, REPROVe, retention, Rindopepimut, Simon, simplify, spinal, strain, studying, Sun, surfaced, surviving, SYSUCC, Tanguturi, tolerability, tolerated, travel, treasury, Vulnerable, Waterhouse, Wuhan, XRT, Zarrabian
Filing tables
Filing exhibits
KTRA similar filings
Filing view
External links
Exhibit 21.1
List of Subsidiaries
Del Mar Pharmaceuticals (BC) Ltd. (British Columbia, Canada)
0959454 B.C. Ltd. (British Columbia, Canada)
0959456 B.C. Ltd. (British Columbia, Canada)
Adgero Biopharmaceuticals Holdings, Inc. (Delaware)
Adgero Biopharmaceuticals, Inc. (Delaware)